SEC Form 4 · accession 0001140361-18-027597
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 7:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2018 | F | 6,310 | $92.07 | D | 284,290 | D | |
| Common Stock | holding | — | — | — | 182,201 | I | Shares held by Jean-Jacques Bienaime Family Trust |
Table II — derivative securities
No Table II lines on this filing.